Anne-Gaëlle Planson’s research interests lie in the field of synthetic biology, with a particular focus on genome engineering, metabolic engineering and the engineering of synthetic consortia. Her projects involve both the construction and optimization of cellular chassis for the production of compounds of industrial and pharmaceutical interest, and the understanding of the fundamental molecular mechanisms that govern biological regulation.
In particular, she is focusing on two main areas. The first involves studying the modes of action of toxic antibacterial compounds, in order to better understand how these compounds affect bacterial cells and potentially develop new antimicrobial strategies.
The second axis focuses on the dynamics of synthetic consortia, in terms of stability, resilience and interactions between subpopulations within a consortium.
These combined studies will enable the development of optimized biological systems for various biotechnological applications.
Short curriculum vitae:
Anne-Gaëlle Planson obtained her PhD in biophysics and protein engineering from the Institut Pasteur (Paris, France), successfully applied for a fellowship in molecular genetics at Harvard Medical School (Boston, MA, USA), and has developed metabolic engineering projects in J.L. Faulon’s laboratory (ISSB, Genopole, Evry, France). Since 2013, A.-G Planson is developing synthetic biology’s projects in M. Jules’s laboratory (SyBER, MICALIS, INRAE, Jouy-en-Josas, France) in genome engineering and bacterial consortia.
She is also co-coordinator of the genome engineering network supported by the MICA department of INRAe, and member of the CCUPS 64-69 of Paris Saclay (Consultative Committee of the University of Paris Saclay for CNU sections 64 to 69).
anne-gaelle-planson 
